Effect of Long-term Psoriasis on Patients' Life - CORONATE
NCT05555953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 543
Last updated 2024-10-26
Summary
Psoriasis, is an inflammatory chronic skin disease which has a heavy physical and psychosocial impact on participant's life. This is a study to finalize and validate a questionnaire to assess the long-term effect of long-term psoriasis in adult participants.
Approximately 550 adult participants with moderate to severe plaque psoriasis will be enrolled in approximately 15 dermatology centers in Italy.
Participants will receive standard of care while participating in this study. No drug will be administered as a part of this study. The duration of this study is up to 22 months.
There is no additional burden for participants in this study. Participants will attend regular visits during the course of the study at a hospital or clinic.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-26
- Primary Completion
- 2024-10-17
- Completion
- 2024-10-17
Countries
- Italy
Study Locations
More Related Trials
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
CP-690-550 Ointment For Chronic Plaque Psoriasis
NCT01246583 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
NCT01815424 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
NCT06801821 ·Status: RECRUITING
-
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
NCT03832738 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
NCT02239666 ·Status: COMPLETED
-
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
NCT00195507 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
NCT01147874 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
NCT00477191 ·Status: TERMINATED ·Phase: NA
-
Improvement of Psoriasis Patients' Adherence to Topical Drugs
NCT04220554 ·Status: COMPLETED ·Phase: NA
-
Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy
NCT06102356 ·Status: COMPLETED
-
Aggressive Weight Loss Program in Chronic Plaque Psoriasis
NCT03531528 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00678210 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
NCT05144165 ·Status: UNKNOWN
-
Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current
NCT01765985 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Body PSOriasis: Long-term Relapse CONTROL
NCT03402828 ·Status: COMPLETED
-
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT04765332 ·Status: COMPLETED
-
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
NCT07261306 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of BFH772 in Psoriasis Patients
NCT00987870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of COVID 19 on Psoriasis Patients
NCT05381402 ·Status: UNKNOWN